GETTING MY MODAFINIL NORGE TO WORK

Belzutifan can be a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may increase incidence or severity of adverse effects. Monitor for anemia and hypoxia and reduce belzutifan dose as advised.Excessive sleepiness is The lack to stay awake in the course of circumstances when wake-fulness and alertness are necessary or anticipated (Arand